Home  >  Products  >  GCET2 (germinal center expressed transcript 2) Blocking Peptide (the middle region of protein) (100ug)
GCET2 (germinal center expressed transcript 2) Blocking Peptide (the middle region of protein) (100ug)

GCET2 (germinal center expressed transcript 2) Blocking Peptide (the middle region of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-GCET2 antibody (Catalogue #: ARP55553_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP55553
Size: 100 ug
Weight: 21kDa
Gene: 257144
Format: Lyophilized powder
Target: GCET2 is a protein which may function in signal transduction pathways and whose expression is elevated in germinal cell lymphomas. It contains a putative PDZ-interacting domain, an immunoreceptor tyrosine-based activation motif (ITAM), and two putative SH2 binding sites. In B cells, its expression is specifically induced by interleukin-4.This gene encodes a protein which may function in signal transduction pathways and whose expression is elevated in germinal cell lymphomas. It contains a putative PDZ-interacting domain, an immunoreceptor tyrosine-based activation motif (ITAM), and two putative SH2 binding sites. In B cells, its expression is specifically induced by interleukin-4. Alternative splicing results in multiple transcript variants encoding different isoforms.
Alternative names: GCAT2; HGAL; MGC40441
See Full Product Listings >